Literature DB >> 6967197

Prolonged effects of large-dose methylprednisolone infusion in multiple sclerosis.

J L Trotter, W F Garvey.   

Abstract

Three daily 1-gm doses of methylprednisolone were administered to 12 patients with multiple sclerosis. Granulocytes, lymphocytes, T and B lymphocytes, lymphocyte transformation in response to several mitogens and one antigen, plasma cortisol, and serum IgM and IgA all returned to baseline within a few days. However, total white blood count, unstimulated lymphocyte incorporation of 3H-thymidine, hematocrit, serum IgG, and cerebrospinal fluid IgG synthesis remained altered 1 week after the infusion. The relationship of these changes to any clinical effects is unknown.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967197     DOI: 10.1212/wnl.30.7.702

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Intravenous methylprednisolone for multiple sclerosis in relapse.

Authors:  M P Barnes; D E Bateman; P G Cleland; D J Dick; T J Walls; P K Newman; M Saunders; P J Tilley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-02       Impact factor: 10.154

2.  Immunological treatment of multiple sclerosis. II.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1986-04       Impact factor: 4.849

3.  A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 2. Laboratory results.

Authors:  D A Compston; N M Milligan; P J Hughes; J Gibbs; V McBroom; B P Morgan; A K Campbell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

Review 4.  Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.

Authors:  D E Goodkin
Journal:  West J Med       Date:  1994-09

5.  The influence of disease activity on the number of blood cells of multiple sclerosis patients.

Authors:  U Patzold; U Wurster; K Mardt; M Schiemann
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

6.  The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.

Authors:  M B Richter; P Woo; G S Panayi; A Trull; A Unger; P Shepherd
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

7.  Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.

Authors:  B Rocchelli; M Poloni; P Mazzarello; G Piccolo; M Delodovici; P Pinelli
Journal:  Ital J Neurol Sci       Date:  1982-07

8.  Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test.

Authors:  Z Lević; D Micić; J Nikolić; N Stojisavljević; D Sokić; S Janković; A Kendereski; M Mavra
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

9.  Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus.

Authors:  D A Isenberg; W J Morrow; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

10.  Immunocytochemical localization of glucocorticoid receptors in the spinal cord: effects of adrenalectomy, glucocorticoid treatment, and spinal cord transection.

Authors:  M Ferrini; S González; T Antakly; A F De Nicola
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.